Want $300 in Super-Safe Dividend Income in 2026? Invest $2,670 Into the Following 3 Ultra-High-Yield Stocks.The Motley Fool • 12/30/25
3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right NowThe Motley Fool • 12/27/25
Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In JanuarySeeking Alpha • 12/27/25
PFE's Oncology & Obesity Pipeline Position It for Post-LOE GrowthZacks Investment Research • 12/24/25
Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 12/23/25
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?The Motley Fool • 12/22/25
Pfizer Down After It Issues Muted 2026 Outlook: How to Play the StockZacks Investment Research • 12/19/25
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with AnalystsBusiness Wire • 12/18/25
Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?Zacks Investment Research • 12/17/25
Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling BackBenzinga • 12/17/25
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin EligibilityPRNewsWire • 12/17/25
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 12/16/25